S

Smith+Nephew

Global medical devices for orthopedics

Health, Safety and Environmental Manager

Full-TimeUpdated on 10/23/2026
No salary listed
Senior, Expert
Bachelor's
Oklahoma City, OK, USA
In PersonWork is performed in both an office environment and at the site; occasional evening or weekend work may be required.
Facilities OperationsEnvironmental Health & Safety

About the job

Requirements
  • A bachelor's degree in occupational safety, environmental science, engineering, or a related field is required.
  • Eight to twelve years of HSE management experience is required.
  • Knowledge of modern developments, principles, and practices of occupational safety and health, including the recognition and control or elimination of workplace hazards.
  • Knowledge and application of the Occupational Safety and Health Act, Environmental Protection Agency requirements, and state and local requirements.
  • Knowledge of management principles related to occupational safety and health, training and education technology, safety management principles, and consultation techniques.
  • Ability to identify and evaluate workplace safety hazards and other potential adverse effects on workers.
  • Ability to research safety problems and apply findings to implementation status.
  • Ability to write detailed technical reports documenting exposures to safety hazards, violations, and controls.
  • Ability to communicate orally with leadership, committees, and employees to relay information, respond to complaints, and clarify or interpret safety rules.
  • Ability to motivate employees to improve workplace safety.
  • Ability to conduct accident, incident, and complaint investigations.
  • Ability to represent the company at formal regulatory site meetings and conferences as an HSE expert.
  • Ability to operate and calibrate some equipment used to measure hazardous substances.
  • Ability to train employees, evaluate progress, review reports, assess training needs, and present training to small and large groups.
  • Ability to conduct meetings and serve as a group leader on special projects.
  • Proficiency with Microsoft Excel, Word, and PowerPoint.
  • Ability to develop and present technical training programs in a specialty field.
  • Ability to provide technical consultation or compliance assistance to management staff and employees.
  • Ability to work independently, analyze and resolve problems with minimal supervision, and exercise judgment and initiative.
  • Knowledge of financial control practices and procedures.
  • Ability to communicate effectively and promptly through oral and written channels.
  • Ability to collaborate, listen actively, maintain effective working relationships, and work with multiple priorities in a fast-paced, changing environment.
  • Ability to handle sensitive matters, remain calm in difficult situations, and maintain strong organizational skills.
  • Must possess a valid driver's license.
  • Must possess a CSP, CIH, CHMM, or equivalent professional certification.
  • Must possess OSHA training credentials, such as OSHA 30-hour training.
  • Work is performed in an office environment and at the site, with frequent interruptions and irregularities in the work schedule.
  • The role requires occasional bending, standing, kneeling, climbing ladders, reaching below and above the shoulders, and lifting objects weighing up to 50 pounds.
  • The role may require walking, climbing ladders, entering cramped and difficult locations, and working in dusty or dirty environments.
  • Working hours may vary, and occasional evening or weekend work is required.
  • The role may involve occasional lifting, guiding, or carrying materials and exposure to potentially hazardous conditions, noise, and temperature extremes.
Responsibilities
  • Develop, implement, and manage site HSE policies, procedures, and programs aligned with corporate and regulatory requirements.
  • Promote a strong safety culture through visible leadership, coaching, and employee engagement.
  • Lead site hazard identification, risk assessments, and job hazard assessments.
  • Conduct and coordinate safety training programs, including new-hire orientation and refresher training.
  • Partner with supervisors and managers to improve safe work practices and accountability.
  • Ensure compliance with OSHA or applicable regulatory agencies, environmental requirements, and industry standards.
  • Maintain required permits, licenses, and regulatory documentation.
  • Serve as the primary site contact for regulatory inspections and audits.
  • Monitor regulatory changes and assess their impact on manufacturing operations.
  • Lead incident investigations, root-cause analyses, and corrective-action development.
  • Track, analyze, and report safety and environmental performance metrics, including TRIR, LTIR, near misses, observations, and environmental incidents.
  • Ensure timely reporting to internal stakeholders and regulatory authorities as required.
  • Oversee environmental programs covering waste management, hazardous materials, emissions, wastewater, and recycling.
  • Support environmental sustainability initiatives and pollution-prevention efforts.
  • Ensure proper handling, storage, and disposal of chemicals and hazardous waste.
  • Plan and conduct internal HSE audits and inspections across operations.
  • Support corporate and third-party audits.
  • Drive continuous-improvement initiatives using leading and lagging indicators.
  • Promote best practices and standardization across site processes.
  • Work with operations, engineering, maintenance, training, and human resources to integrate HSE into daily operations.
  • Provide regular HSE performance updates to site leadership and corporate teams.
  • Support contractors and visitors by ensuring compliance with site HSE requirements.

About the company

Smith+Nephew is a global medical technology company that designs and makes medical devices for orthopaedics, sports medicine, and advanced wound care. Its products help surgeons treat joints and soft tissues and support patient recovery, including knee repair systems, single-use negative pressure wound therapy devices, and other extremity orthopaedic products. These devices are used in hospitals and clinics to perform procedures and support healing, often after surgery or injury. The company differentiates itself with a broad, worldwide product portfolio and collaborations with healthcare organizations to improve care and efficiency for patients and providers. Its goal is to improve patient outcomes, streamline medical procedures, and expand access to advanced medical solutions around the world.

Company Size

10,001+

Company Stage

IPO

Headquarters

Watford, United Kingdom

Founded

1856

Get referred to Smith+Nephew

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue reached $1.5 billion, and full-year guidance stayed intact on May 6.
  • New launches in 2026 include CORI XT, FLOW FLEXTEND, and ALLEVYN COMPLETE CARE.
  • August 2026 H1 results showed 4.6% growth, $200 million efficiency savings, and $500 million buyback.

What critics are saying

  • Reuters on August 4, 2026 cut revenue guidance to around 4% after weak U.S. knees.
  • Smith+Nephew’s finance chief John Rogers exits September 30, 2026, creating leadership churn.
  • A March 2026 humeral nail recall and older hip litigation expose recurring quality risk.

What makes Smith+Nephew unique

  • Smith+Nephew’s CORI XT robotics spans knee, shoulder, and future hip workflows.
  • Its ASC Solutions bundles facility design, financing, and clinical enablement for outpatient surgery.
  • ALLEVYN, RENASYS, and LEAF create a broad wound-care platform with measurable outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Holidays
  • Flexible Work Hours
  • Parental Leave
  • Fertility Treatment Support
  • Family Planning Benefits
  • Tuition Reimbursement

Company News

Yahoo Finance
Oct 23rd, 2026
Smith & Nephew's $22B talks to buy J&J's orthopaedics unit collapse over who would lead

Smith & Nephew's merger talks with Johnson & Johnson (J&J) over its orthopaedics unit collapsed over who would lead the combined company, the Financial Times reported. The sides had reportedly agreed on the main financial terms and the deal structure. J&J wanted Namal Nawana, who runs its orthopaedics unit and formerly led Smith & Nephew, to lead the business. Smith & Nephew wanted current chief executive officer Deepak Nath to stay. Smith & Nephew's offer valued J&J's hip and knee unit at up to $22 billion, almost double its own market value. J&J shareholders would have owned 50.1% of the combined company. J&J is leaning toward spinning off the unit as DePuy Synthes, targeting mid-2027. Reuters reported the unit sought around $20 billion and drew private equity interest. Both companies declined to comment.

Yahoo Finance
Oct 18th, 2026
Three undervalued UK stocks for October 2026: Morgan Sindall, Shell, Smith & Nephew

Simply Wall St has named three London-listed stocks it says trade below estimated fair value based on future cash flows: Morgan Sindall Group, Shell, and Smith & Nephew. The screen flags 23 more companies not covered. Morgan Sindall Group, a £1.8b construction and regeneration firm, saw its secured order book rise 39% to £12bn. Its Partnership Housing arm ties it to long-term contracts, though policy changes and planning delays pose risks. Shell has a market value of about £225.1b and revenue of $443.2b. Its LNG portfolio exceeds 60 million tons. Smith & Nephew, valued at £9.1b, relies on repeat implant procedures. New products drove 75% of first-half growth.

Yahoo Finance
Oct 6th, 2026
Smith+Nephew launches CARTIHEAL AGILI-C cartilage repair implant in Europe

Smith+Nephew has launched its CARTIHEAL AGILI-C Cartilage Repair Implant in Europe. The product, already introduced in the US during 2024, will be featured at the International Cartilage Regeneration & Joint Preservation Society Summit in Porto, Portugal from 8-10 October. The implant, composed of aragonite (a naturally occurring calcium carbonate), acts as a biphasic scaffold to repair cartilage, restore bone and relieve pain. A recent study published in the American Journal of Sports Medicine showed the implant resulted in higher overall Knee injury and Osteoarthritis Outcome Scores versus surgical standard of care for all time points out to 60 months. The implant will initially launch in twelve countries including Austria, Belgium, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Portugal, Spain, Switzerland and the UK.

Kalkine Media
Sep 10th, 2026
Smith+Nephew issues $700M 5.750% bonds due 2036 to refinance 2030 senior notes

Smith & Nephew has issued $700 million in senior notes with a 5.750% coupon maturing in 2036, netting $690.9 million after underwriting fees. The FTSE 100 medical technology firm will primarily use proceeds to fund a tender offer for its existing 2.032% senior notes due 2030, with remaining funds allocated to general corporate purposes. The refinancing replaces lower-yield debt with higher-coupon notes, reflecting current credit market conditions. BofA Securities, J.P. Morgan Securities, Mizuho Securities USA, and SMBC Nikko Securities America managed the transaction, which closed on 11 September 2026. Founded in Hull in 1856, Smith & Nephew operates across orthopaedics, sports medicine, ENT, and advanced wound management. The company employs approximately 17,000 people across 100 countries and reported annual sales of $6.2 billion in 2025.

Ticker Report
Sep 3rd, 2026
Corient Private Wealth LP Makes New $2 Million Investment in Smith & Nephew SNATS, Inc. $SNN

Corient Private Wealth LP purchased a new stake in Smith & Nephew SNATS, Inc. (NYSE:SNN – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 31,871 shares of the medical equipment provider’s stock, valued at approximately $1,999,000. Other large investors […]